GO:0003963 RNA-3'-phosphate cyclase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003963 RNA-3'-phosphate cyclase activity catalyzes the ATP-dependent conversion of an RNA 3'-terminal phosphate into a 2',3'-cyclic phosphodiester, releasing AMP and diphosphate.
• The enzyme is conserved across Eucarya, Bacteria and Archaea, and defines a distinct protein family with unusual topology.
• Human RTCB/RCL (RNA 3'-phosphate cyclase) is the founding eukaryotic member; its catalytic mechanism and substrate recognition have been resolved structurally.
• The reaction generates a reactive cyclic phosphate that can be used for RNA ligation or further 3'-terminal modification.
• Archaeal and bacterial homologs show variations in nucleotide specificity, including a GTP-dependent cyclase in Pyrococcus furiosus.
• Dysregulation of RNA 3'-terminal processing is linked to cancer, neurodegeneration and ribosomopathies, making GO:0003963 a target for functional genomics and CRISPR screening.
Description
RNA 3'-phosphate cyclase activity (GO:0003963) is a molecular function that modifies the 3' end of RNA molecules by converting a terminal phosphate into a 2',3'-cyclic phosphodiester. This reaction, first described in HeLa cell extracts, requires ATP and produces AMP and diphosphate as byproducts. The enzyme responsible, RNA 3'-terminal phosphate cyclase (RTC), is conserved across all three domains of life and defines a unique protein family. Understanding GO:0003963 is essential because cyclic phosphate ends are intermediates in RNA processing, ligation and turnover, and their misregulation can impact gene expression and cellular stress responses. The availability of crystal structures for the human and bacterial enzymes has revealed an unusual topology and a distinct catalytic mechanism, providing a framework for functional studies. Researchers investigating RNA metabolism, tRNA splicing, and RNA-based therapeutics need reliable models to dissect the role of this activity in health and disease.
RNA-3'-phosphate cyclase activity At A Glance
| GO ID | GO:0003963 |
|---|---|
| GO term | RNA-3'-phosphate cyclase activity |
| Ontology | molecular_function |
| Synonym | RNA-3'-phosphate:RNA ligase (cyclizing, AMP-forming); RNA 3'-terminal phosphate cyclase activity; RNA cyclase activity |
| Major function | Catalyzes ATP-dependent conversion of RNA 3'-terminal phosphate to 2',3'-cyclic phosphodiester |
| Reaction | ATP + RNA 3'-terminal-phosphate = AMP + diphosphate + RNA terminal-2',3'-cyclic-phosphate |
| Cofactor | ATP (or GTP in some archaeal homologs) |
| Conservation | Eucarya, Bacteria, Archaea |
| EC number | 6.5.1.4 |
What Is GO:0003963?
GO:0003963 RNA-3'-phosphate cyclase activity is defined as the catalysis of the reaction: ATP + RNA 3'-terminal-phosphate = AMP + diphosphate + RNA terminal-2',3'-cyclic-phosphate. In other words, the enzyme transfers the terminal phosphate of an RNA molecule onto its own 2' hydroxyl, forming a cyclic phosphodiester, while consuming ATP and releasing AMP and pyrophosphate. This activity is synonymous with RNA-3'-phosphate:RNA ligase (cyclizing, AMP-forming), RNA 3'-terminal phosphate cyclase activity, and RNA cyclase activity.
Why Is RNA-3'-phosphate cyclase activity Important in Cell Biology?
GO:0003963 is important because the cyclic phosphate end it generates is a key intermediate in RNA processing and ligation pathways, including tRNA splicing and RNA repair. The enzyme is conserved from bacteria to humans, and its activity influences RNA stability and function. Structural studies have revealed a unique fold and catalytic strategy, making it a model for understanding enzyme evolution and RNA modification. In disease, altered RNA 3'-terminal processing has been implicated in cancer and neurological disorders, highlighting the need for precise functional annotation and experimental models.
• Generates 2',3'-cyclic phosphate ends that are substrates for RNA ligases and nucleases.
• Essential for tRNA splicing and RNA repair in eukaryotes and archaea.
• Conserved in all domains of life, serving as a paradigm for RNA modification enzymes.
• Structural uniqueness provides insights into enzyme mechanism and evolution.
• Human RTCB/RCL is linked to cellular stress responses and RNA turnover.
• Bacterial homologs are regulated by sigma54 and may play roles in stress adaptation.
• Archaeal GTP-dependent cyclases expand the known nucleotide specificity.
• Potential target for antiviral and anticancer strategies targeting RNA processing.
• Useful as a selectable marker or tool in RNA ligation-based assays.
• Dysregulation may contribute to ribosomopathies and neurodegeneration.
Mechanism, Genes and Research Methods
Substrate Recognition and Binding
In simple terms: The enzyme first grabs the RNA molecule by its 3' end.
RNA 3'-phosphate cyclase binds to the 3'-terminal phosphate of RNA substrates. Structural studies of the human enzyme bound to substrate RNA show that the protein uses a conserved pocket to position the terminal phosphate for attack by the 2' hydroxyl. The enzyme recognizes the RNA backbone primarily through the terminal nucleotide, with additional contacts to the penultimate base. This binding mode ensures specificity for RNA over DNA and for 3'-phosphate over 3'-hydroxyl ends.
ATP-Dependent Activation
In simple terms: ATP provides the energy to drive the reaction.
The cyclization reaction requires ATP, which is hydrolyzed to AMP and diphosphate. The enzyme first adenylates the 3'-terminal phosphate, forming a high-energy intermediate, then the 2' hydroxyl attacks this intermediate to form the cyclic phosphodiester. This two-step mechanism is similar to that of DNA and RNA ligases, but the cyclase releases AMP rather than sealing a nick. In some archaea, GTP can substitute for ATP, indicating flexibility in nucleotide usage.
Catalytic Cycle and Product Release
In simple terms: The enzyme creates a ring at the RNA end and then lets it go.
After formation of the 2',3'-cyclic phosphate, the product is released. The reaction is reversible in vitro, but under physiological conditions the cyclic phosphate is rapidly consumed by downstream enzymes such as ligases or nucleases. The catalytic cycle involves conformational changes that have been visualized in crystal structures of the bacterial and human enzymes. The unusual topology of the cyclase domain, with a twisted beta-sheet, is thought to facilitate these movements.
Structural Architecture of the Cyclase Domain
In simple terms: The protein has a distinctive 3D shape that enables its function.
The crystal structure of RNA 3'-terminal phosphate cyclase from Escherichia coli revealed a novel fold with a central beta-sheet surrounded by alpha-helices. The human enzyme shares this core architecture but includes additional insertions that may regulate activity or interactions. The active site is located in a cleft that binds the RNA terminus and ATP. This unique topology distinguishes the cyclase from other ATP-dependent enzymes and supports its classification as a separate protein family.
Regulation and Post-Translational Modifications
In simple terms: The activity of the enzyme can be turned up or down by cellular signals.
The expression of RNA 3'-terminal phosphate cyclase is regulated at the transcriptional level; in E. coli, the gene is part of a sigma54-regulated operon, suggesting control by stress and nitrogen limitation. In eukaryotes, the human enzyme may be subject to post-translational modifications, although specific sites are not fully characterized. The activity can also be influenced by the availability of ATP and the presence of RNA substrates. Further studies are needed to fully elucidate its regulation in vivo.
Key Genes Involved in GO:0003963 RNA-3'-phosphate cyclase activity
The following genes and proteins are directly associated with RNA-3'-phosphate cyclase activity (GO:0003963) or its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RTCB (human) | RNA 3'-phosphate cyclase; catalyzes cyclic phosphate formation | Key enzyme for tRNA splicing and RNA repair; structural studies |
| RTCB (E. coli) | Bacterial homolog; sigma54-regulated | Model for bacterial RNA processing and stress response |
| RTCB (Pyrococcus furiosus) | GTP-dependent cyclase | Archaeal variant with altered nucleotide specificity |
| RCL1 (yeast) | RNA 3'-terminal phosphate cyclase-like | Role in rRNA processing and ribosome assembly |
| RTCB (Drosophila) | Cyclase involved in RNA ligation | Genetic model for RNA processing |
| RTCB (C. elegans) | Cyclase homolog | Developmental roles in RNA metabolism |
| RTCB (Arabidopsis) | Plant cyclase | Stress-responsive RNA processing |
| RTCB (zebrafish) | Vertebrate cyclase | Developmental and neurological functions |
| RTCB (mouse) | Mammalian cyclase | Knockout models for tRNA splicing and neurodegeneration |
| RTCB (rat) | Cyclase in neuronal tissues | Implications for synaptic function |
| RTCB (Xenopus) | Cyclase in oocytes | RNA storage and translation control |
| RTCB (Trypanosoma) | Cyclase in kinetoplastids | RNA editing and processing |
| RTCB (Methanocaldococcus) | Archaeal cyclase | Thermostable enzyme for biotechnology |
| RTCB (Sulfolobus) | Archaeal cyclase | RNA modification in extreme environments |
| RTCB (human) variants | Point mutants affecting catalysis | Structure-function analysis |
| RTCB (bacterial) operon | Co-regulated with sigma54 | Gene regulation studies |
| RTCB (viral homologs) | Mimics of cyclase | Host-pathogen interactions |
| RTCB (fungal) | Cyclase in fungi | Antifungal target potential |
How Is RNA-3'-phosphate cyclase activity Regulated?
The expression and activity of RNA 3'-phosphate cyclase are regulated at multiple levels. In bacteria, the rtcB gene is part of a sigma54-dependent operon, linking its expression to nitrogen and stress responses. In eukaryotes, transcription of the human RTCB gene may be influenced by growth conditions and stress, although specific transcription factors remain to be defined. The enzyme requires ATP, so its activity is indirectly tied to cellular energy status. Additionally, the availability of RNA substrates with 3'-terminal phosphate ends, generated by nucleases or other processing events, can limit the reaction rate. Post-translational modifications have not been extensively mapped but could modulate activity or localization.
RNA-3'-phosphate cyclase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RTCB (human) | Cancer, neurodegeneration | Knockout and overexpression in cancer cell lines; neuronal models |
| RTCB (mouse) | Neurodegeneration, tRNA splicing defects | Conditional knockout mice; point-mutation knock-in |
| RTCB (yeast) | Ribosomopathy, rRNA processing | Yeast deletion strains; rescue with human ortholog |
| RTCB (E. coli) | Stress response, sigma54 regulation | Bacterial knockout and reporter assays |
| RTCB (archaeal) | RNA modification in extreme environments | Thermostable enzyme assays; structural studies |
Cancer
Altered RNA 3'-terminal processing has been observed in cancer cells, where changes in tRNA splicing and RNA repair can promote proliferation and survival. The human RNA 3'-phosphate cyclase (RTCB) is overexpressed in some tumors, and its activity may support the processing of tRNAs that are critical for protein synthesis under stress. Targeting this enzyme could sensitize cancer cells to chemotherapy, although further studies are needed to validate its role as a therapeutic target.
Neurodegeneration
Defects in tRNA splicing and RNA modification have been linked to neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and pontocerebellar hypoplasia. Mutations in RTCB or its partners can impair the cyclization step, leading to accumulation of unprocessed tRNAs and neuronal stress. Animal models with reduced RTCB activity show motor neuron degeneration, highlighting the importance of GO:0003963 in neuronal health.
Ribosomopathies
Ribosome assembly requires proper processing of rRNA and tRNA. The cyclase activity of RTCB contributes to the maturation of tRNAs and possibly rRNA, and its dysfunction may lead to ribosomopathies characterized by bone marrow failure and developmental defects. However, direct evidence linking RTCB mutations to specific ribosomopathies is still emerging.
From RNA-3'-phosphate cyclase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does RTCB loss affect tRNA splicing and cell viability? | CRISPR knockout in human cell lines (e.g., HeLa, HEK293) |
| What is the catalytic role of specific residues? | Point mutations in RTCB (e.g., active-site mutants) via CRISPR knock-in |
| How does RTCB overexpression impact RNA processing? | Doxycycline-inducible overexpression in mammalian cells |
| What are the interaction partners of RTCB? | Endogenous tagging with FLAG/HA using knock-in for proteomics |
| Does RTCB mutation cause neurodegeneration in vivo? | Conditional knockout or point-mutation knock-in mice |
| Can RTCB activity be monitored in real time? | Fluorescent RNA substrates and live-cell imaging |
How to Study the RNA-3'-phosphate cyclase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Changes in RNA processing and abundance | Knockout vs wild-type cells |
| Ribo-seq | Translation efficiency and ribosome occupancy | Effect of RTCB loss on protein synthesis |
| AP-MS | Protein-protein interactions | Identifying RTCB partners |
| X-ray crystallography | 3D structure of enzyme-RNA complexes | Mechanistic studies |
| In vitro cyclization assay | Enzymatic activity | Mutant characterization |
| CRISPR screening | Genes required for RNA processing | Functional genomics |
| Live-cell imaging | Localization and dynamics of RTCB | Subcellular distribution studies |
RNA Sequencing and Ribo-Seq
RNA-seq can detect changes in tRNA and rRNA processing upon RTCB perturbation, while Ribo-seq reveals effects on translation. These methods help link GO:0003963 activity to global RNA metabolism.
Proteomics and Interactomics
Affinity purification coupled to mass spectrometry (AP-MS) of tagged RTCB identifies interacting proteins, including ligases and RNA-binding proteins. This approach clarifies the functional network of the cyclase.
Structural Biology
X-ray crystallography and cryo-EM have been used to solve structures of RTCB alone and bound to RNA, revealing the catalytic mechanism and substrate specificity.
Enzymatic Assays
In vitro cyclization assays using radiolabeled or fluorescent RNA substrates measure the conversion of 3'-phosphate to 2',3'-cyclic phosphate. These assays are used to test mutants and inhibitors.
How CRISPR Can Be Used to Study GO:0003963 RNA-3'-phosphate cyclase activity
Knockout
CRISPR knockout of RTCB in human cell lines abolishes RNA 3'-phosphate cyclase activity, leading to accumulation of unprocessed tRNAs and growth defects. These models are essential to study the loss-of-function phenotype and to validate the enzyme's role in tRNA splicing.
Point Mutation
Introducing point mutations in the active site of RTCB (e.g., substituting catalytic residues) via CRISPR knock-in allows precise dissection of the catalytic mechanism without affecting protein stability. Such mutants can be used to separate cyclization from other functions.
Knock-in
Knock-in of epitope tags (e.g., FLAG, HA) at the endogenous RTCB locus enables endogenous expression and purification for interaction studies. This approach preserves physiological regulation and avoids overexpression artifacts.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of RTCB can be used to study gain-of-function effects, such as enhanced RNA processing or resistance to stress. Overexpression models help identify downstream targets and potential oncogenic roles.
How EDITGENE Supports RNA-3'-phosphate cyclase activity Research
Researchers studying RNA-3'-phosphate cyclase activity-related genes often need to determine whether a candidate gene is causally involved in RNA processing, disease, or cellular stress responses. EDITGENE provides a comprehensive suite of CRISPR-based services to create precisely engineered cell models, enabling functional validation and drug discovery.
Contact EDITGENE today to design your custom CRISPR model for RNA-3'-phosphate cyclase activity research.
Frequently Asked Questions About RNA-3'-phosphate cyclase activity
What is RNA-3'-phosphate cyclase activity?
It is an enzymatic activity (GO:0003963) that converts an RNA 3'-terminal phosphate into a 2',3'-cyclic phosphodiester using ATP, releasing AMP and diphosphate.
What genes are involved in RNA-3'-phosphate cyclase activity?
The primary gene is RTCB (also known as RCL) in humans, with homologs in bacteria, archaea, and other eukaryotes.
What is the reaction catalyzed by RNA-3'-phosphate cyclase?
ATP + RNA 3'-terminal-phosphate = AMP + diphosphate + RNA terminal-2',3'-cyclic-phosphate.
Why is RNA-3'-phosphate cyclase important?
It generates cyclic phosphate ends that are intermediates in RNA splicing, ligation, and repair, and is conserved across all domains of life.
What diseases are associated with RNA-3'-phosphate cyclase?
Dysregulation has been linked to cancer, neurodegeneration, and ribosomopathies, though direct causal mutations are still under investigation.
How can I study RNA-3'-phosphate cyclase activity?
Common methods include in vitro enzymatic assays, RNA-seq, Ribo-seq, and structural biology, as well as CRISPR knockout and knock-in models.
What is the structure of RNA-3'-phosphate cyclase?
It has a unique topology with a central beta-sheet, as revealed by crystal structures of the bacterial and human enzymes.
Is RNA-3'-phosphate cyclase conserved in bacteria?
Yes, the enzyme is found in bacteria, including E. coli, where it is part of a sigma54-regulated operon.
Can RNA-3'-phosphate cyclase use GTP?
Some archaeal homologs, such as that from Pyrococcus furiosus, are GTP-dependent, unlike the ATP-dependent eukaryotic and bacterial enzymes.
What are the research tools for RNA-3'-phosphate cyclase?
CRISPR knockout, point mutation, knock-in tagging, overexpression, and CRISPR screening are available from EDITGENE to study this activity.
Conclusion
GO:0003963 RNA-3'-phosphate cyclase activity is a conserved enzymatic function critical for RNA 3'-terminal modification, tRNA splicing, and RNA repair. Its unique structure and mechanism have been elucidated through decades of biochemical and structural studies. Dysregulation of this activity is implicated in cancer and neurodegeneration, making it a compelling target for functional genomics. EDITGENE provides comprehensive CRISPR services to create precise cell models for studying this activity and its role in disease.
References
- 1. Desai KK et al.. 2014. Structure of RNA 3'-phosphate cyclase bound to substrate RNA.. RNA 20(10):1560-6 PMID: 25161314
- 2. Filipowicz W et al.. 1983. RNA 3'-terminal phosphate cyclase activity and RNA ligation in HeLa cell extract.. Nucleic Acids Res 11(5):1405-18 PMID: 6828385
- 3. Tanaka N et al.. 2009. Structure-activity relationships in human RNA 3'-phosphate cyclase.. RNA 15(10):1865-74 PMID: 19690099
- 4. Sato A et al.. 2011. GTP-dependent RNA 3'-terminal phosphate cyclase from the hyperthermophilic archaeon Pyrococcus furiosus.. Genes Cells 16(12):1190-9 PMID: 22074260
- 5. Genschik P et al.. 1998. Characterization of the Escherichia coli RNA 3'-terminal phosphate cyclase and its sigma54-regulated operon.. J Biol Chem 273(39):25516-26 PMID: 9738023
- 6. Genschik P et al.. 1997. The human RNA 3'-terminal phosphate cyclase is a member of a new family of proteins conserved in Eucarya, Bacteria and Archaea.. EMBO J 16(10):2955-67 PMID: 9184239
- 7. Palm GJ et al.. 2000. Crystal structure of RNA 3'-terminal phosphate cyclase, a ubiquitous enzyme with unusual topology.. Structure 8(1):13-23 PMID: 10673421
- 8. Zhelkovsky AM et al.. 2014. Polynucleotide 3'-terminal phosphate modifications by RNA and DNA ligases.. J Biol Chem 289(48):33608-16 PMID: 25324547
